30th Nov 2005 07:00
Tepnel Life Sciences PLC30 November 2005 Tepnel Life Sciences plc (the "Company") Board Change and Trading Update The Company (AIM: TED), the UK-based international Molecular Diagnostics andResearch Products & Services group, announces that it has terminated thecontract of Gron Ffoulkes-Davies, Group Finance Director, with immediate effect. Michael Slater, who has recently joined the Company as Group FinancialController, will take day-to-day responsibility for the finance and accountingfunction until the appointment of a new Finance Director. The Company also can confirm that trading at both its divisions continues to bein line with market expectations and the Board looks forward to a satisfactoryoutcome for the year ended 31 December 2005. Enquiries: Ben Matzilevich, Chief Executive Officer, Tepnel Life Sciences plc 0161 946 2200Mark Percy, Seymour Pierce Limited 0207 107 8000Richard Anderson, De Facto Communications Ltd 0207 940 1000 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L